RAC2 and cancer: The diagnosis age of RAC2 missense-mutant cancer patients (median,5 7.5; interquartile range, 51.75-69) and RAC2 splicing-mutant cancer patients (median,73; interquartile range, 61.25-81) was not statistically different from the those with RAC2 nonmutant disease (median, 60; interquartile range, 25-69).